Early research (Phase 1)Study completedNCT00420043What this trial is testingEffect of Food on Bioavailability of Modified Release Formulations of ImatinibWho this might be right forHealthy Novartis 32
Large-scale testing (Phase 3)Temporarily pausedNCT01755325What this trial is testingPhase III Study of Compound Formula Realgar-Indigo Naturalis Plus Imatinib Versus Placebo Plus Imatinib in Adult CML-CP Patients With Ph+Who this might be right forChronic Myelogenous Leukemia Junmin Li 680
Early research (Phase 1)Ended earlyNCT01751425What this trial is testingRuxolitinib in Treating Participants With Chronic Myeloid Leukemia With Minimal Residual Disease While on Therapy With Tyrosine Kinase InhibitorsWho this might be right forChronic Myelogenous Leukemia, BCR-ABL1 PositiveChronic Myelogenous Leukemia, BCR-ABL1 Positive in RemissionMinimal Residual Disease+1 more M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT01207440What this trial is testingPonatinib for Chronic Myeloid Leukemia (CML) Evaluation and Ph+ Acute Lymphoblastic Leukemia (ALL)Who this might be right forChronic Myeloid LeukemiaPh+ Acute Lymphoblastic Leukemia Ariad Pharmaceuticals 449
Large-scale testing (Phase 3)Active Not RecruitingNCT05456191What this trial is testingInvestigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)Who this might be right forPhiladelphia Chromosome-Positive Chronic Myeloid Leukemia Novartis Pharmaceuticals 568
Testing effectiveness (Phase 2)Ended earlyNCT00644878What this trial is testingStudy of Molecular Response in Adult Patients on Nilotinib With Philadelphia Chromosome Positive Chronic Myelogenous Leukemia (Ph+ CML) in Chronic Phase and a Suboptimal Molecular Response to ImatinibWho this might be right forChronic Myelogenous Leukemia - Chronic Phase Novartis Pharmaceuticals 18
Testing effectiveness (Phase 2)Study completedNCT00375219What this trial is testingHomoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene MutationWho this might be right forChronic Myeloid Leukemia Teva Branded Pharmaceutical Products R&D, Inc. 103
Testing effectiveness (Phase 2)Study completedNCT00171249What this trial is testingAn Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ LeukemiaWho this might be right forPhiladelphia Positive Chronic Myeloid LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia Novartis Pharmaceuticals 293
Early research (Phase 1)Study completedNCT02081378What this trial is testingA Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALLWho this might be right forChronic Myelogenous LeukemiaPhiladelphia Chromosome-positive Acute Lymphoblastic Leukemia Novartis Pharmaceuticals 326
Testing effectiveness (Phase 2)Study completedNCT00171158What this trial is testingAn Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Participants With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Blast CrisisWho this might be right forPhiladelphia Chromosome Positive CML Novartis Pharmaceuticals 260
Testing effectiveness (Phase 2)Study completedNCT01593254What this trial is testingStudy of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to ImatinibWho this might be right forChronic Phase Chronic Myeloid Leukemia Bristol-Myers Squibb 262
Testing effectiveness (Phase 2)Study completedNCT00558675What this trial is testingA Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological MalignancyWho this might be right forHematological MalignancyLeukemiaLymphoma+1 more Mirror Biologics, Inc. 6
Testing effectiveness (Phase 2)Study completedNCT00067028What this trial is testingClofarabine Combinations in Relapsed/Refractory Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) and Myeloid Blast Phase Chronic Myeloid Leukemia (CML)Who this might be right forAcute Myeloid LeukemiaMyelodysplastic SyndromeChronic Myeloid Leukemia M.D. Anderson Cancer Center 116
Testing effectiveness (Phase 2)UnknownNCT03883100What this trial is testingA Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Accelerated Phase With T315I MutationWho this might be right forChronic Myeloid Leukemia - Accelerated Phase Ascentage Pharma Group Inc. 23
Testing effectiveness (Phase 2)UnknownNCT02007811What this trial is testingOpen-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single VaccinationWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+5 more University of Erlangen-Nürnberg Medical School 15
Large-scale testing (Phase 3)Looking for participantsNCT03459534What this trial is testingThe Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIsWho this might be right forChronic Myeloid Leukemia, Chronic PhaseCML, Chronic PhaseCML, Refractory+1 more Il-Yang Pharm. Co., Ltd. 173
Early research (Phase 1)Study completedNCT02890758What this trial is testingPhase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803Who this might be right forAcute Myeloid LeukemiaMyelodysplastic SyndromeAcute Lymphoblastic Leukemia+11 more Brenda Cooper, MD 14
Early research (Phase 1)Study completedNCT01164163What this trial is testingINCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative DiseaseWho this might be right forChronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+2 more Children's Oncology Group 49
Early research (Phase 1)Ended earlyNCT00464113What this trial is testingStudy of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic LeukemiaWho this might be right forChronic Myeloid LeukemiaLeukemia, Lymphoblastic, Acute, Philadelphia-Positive Exelixis 49
Testing effectiveness (Phase 2)Study completedNCT01294618What this trial is testingNilotinib + Pegylated Interferon Alpha 2a for Untreated Chronic Phase Chronic Myelogenous LeukemiaWho this might be right forChronic Myelogenous Leukemia Hospices Civils de Lyon 60